DMSO as a Skin Penetration Enhancer: Mechanism, Concentration & Cosmetic Use
The molecular biology of how DMSO opens the stratum corneum - and what the concentration curve means for formulators.
Dimethyl sulfoxide (DMSO, CAS 67-68-5) is the original - and still one of the most studied - chemical skin penetration enhancers. It is the reason the FDA-approved topical analgesic Pennsaid can deliver diclofenac through the skin, and the reason cosmetic formulators add DMSO to serums when they need an active to reach the deeper epidermis. But the mechanism is more nuanced than "it just dissolves the skin barrier." Decades of molecular-dynamics simulation and spectroscopy have revealed a strongly concentration-dependent effect with two distinct regimes.
This article explains how DMSO interacts with the stratum corneum at the molecular level, why the effect changes so dramatically with concentration, how DMSO compares with ethanol, azone, and other enhancers, and what all of this means for formulators sourcing cosmetic- and pharma-grade DMSO. It is the molecular-biology companion to our DMSO pharmaceutical & personal-care sourcing guide.
01. The Skin Barrier 101 🧱
To understand how DMSO works, you first have to understand what it is working against. The outermost layer of the skin - the stratum corneum (SC) - is the primary barrier to anything entering or leaving the body through the skin. It is often described with a "brick and mortar" model:
- The "bricks" are corneocytes - flattened, dead, keratin-filled cells stacked 15–20 layers deep.
- The "mortar" is a continuous extracellular lipid matrix made of ceramides (≈50 %), cholesterol (≈25 %), and free fatty acids (≈15 %), arranged in highly ordered, tightly packed lamellar bilayers in a "gel phase."
Because the lipid matrix is continuous while the corneocytes are not, the lipid "mortar" is the main pathway for molecules crossing the skin. The tighter and more ordered those lipid bilayers are, the harder it is for anything - water, drugs, cosmetics actives - to get through. A penetration enhancer works by reversibly disordering this lipid packing.
02. How DMSO Fluidizes Lipid Bilayers 🔬
Molecular-dynamics simulations of DMSO interacting with ceramide bilayers - published in the Biophysical Journal (Notman et al., 2007) - give a remarkably clear picture of the molecular mechanism:
- DMSO accumulates in the headgroup region. The polar S=O group of DMSO is attracted to the polar headgroups of the ceramides at the bilayer surface. DMSO molecules concentrate at the lipid–water interface.
- It weakens the lateral forces between ceramides. By inserting into the headgroup zone and disrupting the hydrogen-bond network that holds adjacent ceramide molecules together, DMSO loosens the lateral cohesion of the lipid lattice.
- Above a threshold, the bilayer changes phase. At DMSO concentrations of ≥ 0.4 mole fraction, the ceramide bilayer undergoes a phase transition from the tightly ordered gel phase to a disordered liquid-crystalline phase. The liquid-crystalline phase is dramatically more permeable to solutes than the gel phase.
- It can induce transient water pores. Related simulations on phospholipid bilayers show DMSO can induce transient water pores - additional pathways through which dissolved actives can pass.
03. The Concentration Curve 📈
The single most important practical fact about DMSO as a penetration enhancer is that its effect is strongly concentration-dependent and highly non-linear. This is the finding that separates a working formulation from one that does nothing.
| DMSO Concentration | Penetration Effect | Typical Use |
|---|---|---|
| < 10 % | Minimal lipid-matrix effect; mild co-solvent action | Cosmetic co-solvent, fragrance carrier |
| 10 – 30 % | Modest enhancement, primarily via corneocyte pathway (research suggests little SC-lipid disruption at these levels) | Cosmetic actives, mild topical formulations |
| 30 – 60 % | Strong, increasing enhancement as lipid disordering begins in earnest | Topical analgesics, dermatologic actives |
| ≥ 60 % (≈0.4 mol fraction) | Maximal enhancement - gel-to-liquid-crystalline phase transition of SC lipids | High-potency transdermal delivery, specialty formulations |
The lesson for formulators: the dramatic penetration enhancement DMSO is famous for kicks in at high concentrations (≥ 60 %, roughly 0.4 mole fraction). At the low concentrations common in cosmetics (10–30 %), the effect is much milder and works through a different route - see the next section. This is why a 5 % DMSO cosmetic serum does not behave like a 50 % DMSO pharmaceutical gel.
04. Two Mechanisms - Lipids vs Corneocytes 🔀
Recent research has revealed that DMSO acts through two distinct mechanisms depending on concentration:
At high concentration (≥ 0.4 mole fraction): the dominant mechanism is lipid fluidization - the gel-to-liquid-crystalline phase transition described above. The lipid "mortar" between the corneocytes becomes disordered and permeable.
At cosmetically relevant concentration (10–30 %): spectroscopic and calorimetric studies suggest there is little specific interaction with the SC lipid matrix. Instead, the enhancement at these lower concentrations appears to be realized primarily via the corneocytes - DMSO swells the keratin-filled cells and increases the partition of hydrophilic actives into and through them.
05. DMSO vs Other Penetration Enhancers ⚖️
DMSO is one member of a broad family of chemical penetration enhancers. Here is how it compares with the other common options formulators evaluate:
| Enhancer | Mechanism | Strength | Notes |
|---|---|---|---|
| DMSO | Lipid fluidization (high conc.) + corneocyte swelling (low conc.) | Very strong at ≥60 % | Broad solubilizing power; concentration-dependent; characteristic taste effect |
| Ethanol | Lipid extraction + increased drug solubility | Moderate | Volatile, can dry skin; ubiquitous in transdermal patches |
| Azone (laurocapram) | Inserts into lipid bilayer, disrupts packing | Strong at low conc. | Effective at 1–5 %; purpose-designed enhancer |
| Propylene glycol | Solvent, co-enhancer (synergistic with others) | Weak alone | Often combined with DMSO or azone for synergy |
| Oleic acid | Lipid-phase disruption (fluidization) | Moderate–strong | Forms separate liquid domains in SC lipids |
| Urea | Hydration + keratolytic | Mild | Mainly a humectant; mild enhancement |
DMSO's distinctive advantage is that it is simultaneously a powerful solvent (dissolving the active) and a powerful enhancer (opening the skin). Most other enhancers do only one of these jobs. The trade-off is that DMSO needs high concentrations to deliver its strongest enhancement, whereas purpose-designed molecules like azone work at 1–5 %.
06. Reversibility & Skin Recovery ♻️
A critical property for any penetration enhancer used in repeated-application products is whether the barrier disruption is reversible. For DMSO, the answer is largely yes - the gel-to-liquid-crystalline transition reverses as DMSO clears from the skin, and the lipid lamellae re-order. This reversibility is what makes chronic-use products like Pennsaid (applied daily for months) feasible without permanent barrier damage.
That said, repeated high-concentration exposure can cause transient local effects - reddening, scaling, a warm or stinging sensation. These resolve after the product is discontinued. The reversibility depends on concentration, frequency, and the health of the skin barrier at the application site.
07. Use in Topical Pain-Relief Products 💊
The most prominent commercial use of DMSO as a penetration enhancer is in topical pain-relief formulations. The flagship example is Pennsaid, where 45.5 % w/w DMSO carries diclofenac sodium through the skin to treat osteoarthritis of the knee - delivering the NSAID locally while reducing the systemic exposure associated with oral diclofenac.
DMSO also appears in:
- Veterinary topical analgesics for equine and canine musculoskeletal injuries (FDA-approved veterinary indications)
- Compounded topical pain gels combining DMSO with NSAIDs, anesthetics, or muscle relaxants (prepared by compounding pharmacies)
- Specialty dermatologic formulations where deep-tissue delivery of an active is required
08. Formulation & Sourcing Considerations 📦
Five practical considerations when formulating with DMSO as a penetration enhancer:
- Match grade to use. For any human-skin product, use cosmetic-grade (≥ 99.9 %) or pharma-grade (USP / EP) DMSO with batch COA - never technical grade.
- Dial concentration to mechanism. If you need strong transdermal delivery, you'll likely need ≥ 30–60 % DMSO. For mild cosmetic co-solvent action, 5–15 % is typical. Match your label claims to the actual concentration.
- Test for synergy. DMSO combines synergistically with propylene glycol, ethanol, and surfactant enhancers. A lower DMSO concentration plus a co-enhancer can sometimes deliver the same flux with less skin irritation.
- Check packaging compatibility. DMSO formulations ≥ 30 % require HDPE, HDPP, PTFE, or glass primary packaging - PVC, polycarbonate, and most rubbers are incompatible (see our pharmaceutical sourcing guide).
- Validate with permeation studies. Use Franz-cell or equivalent in-vitro permeation testing on your specific formulation. The literature gives the mechanism; your own data gives the regulatory evidence.
Frequently Asked Questions
DMSO penetrates skin by reversibly disordering the lipid bilayers of the stratum corneum (the skin's outer barrier). At high concentrations (≥ 0.4 mole fraction, roughly ≥ 60 %), it triggers a gel-to-liquid-crystalline phase transition in the ceramide lipids, dramatically increasing permeability. At lower cosmetic concentrations (10–30 %), it works more through swelling the corneocytes. The effect is reversible - the barrier recovers as DMSO clears.
The strong, lipid-fluidization mechanism requires roughly ≥ 60 % DMSO (about 0.4 mole fraction). At cosmetically relevant concentrations of 10–30 %, the enhancement is milder and works mainly via the corneocytes. Approved topical pharmaceuticals like Pennsaid use 45.5 % DMSO. Always validate your specific concentration with permeation testing.
Yes. DMSO is the penetration-enhancing carrier in the FDA-approved topical analgesic Pennsaid (diclofenac in 45.5 % DMSO) for osteoarthritis, and it has FDA-approved veterinary uses for equine musculoskeletal injuries. It is also used in compounded topical pain formulations. Any pain-relief product using DMSO must use pharmaceutical-grade material with full documentation.
Largely yes. The lipid disordering reverses as DMSO clears from the skin and the lamellae re-order, which is why chronic-use products like Pennsaid are feasible. Repeated high-concentration exposure can cause transient reddening or stinging that resolves after discontinuation.
DMSO is used in personal-care formulations as a co-solvent and penetration enhancer, typically at 5–15 %. Regulatory status varies by market - it is not currently in the EU Cosmetic Regulation's prohibited or restricted annexes, but local notification may be required. Use cosmetic-grade DMSO and confirm compliance with your target market's regulations before formulating.
📚 Authoritative References
- Biophysical Journal - Notman et al., The Permeability-Enhancing Mechanism of DMSO in Ceramide Bilayers (MD simulation)
- PubMed - Effect of DMSO on the Phase Behavior of Model Stratum Corneum Lipid Mixtures
- NCBI PMC - Structure-Enhancement Relationship of Chemical Penetration Enhancers
- PubChem - Dimethyl Sulfoxide (CID 679)
- U.S. FDA - Inactive Ingredient Database (DMSO topical entries)
🔗 Continue Reading - DMSO Knowledge Hub
Cosmetic & Pharma-Grade DMSO for Topical Formulations
Sinolook Chemical Co., Ltd. supplies cosmetic-grade and pharmaceutical-grade dimethyl sulfoxide (CAS 67-68-5) for penetration-enhancer applications - ≥ 99.9 % purity, batch-specific COA, USP / EP / JP conformance available, HDPE drum / IBC packaging for 50+ countries.
